title: Advances in the regulation of osteoclasts and osteoclast functions.
abstract: Osteoclasts are derived from mononuclear hematopoietic myeloid lineage cells, which are formed in the bone marrow and are attracted to the bloodstream by factors, including sphingsine-1 phosphate. These circulating precursors are attracted to bone surfaces undergoing resorption by chemokines and other factors expressed at these sites, where they fuse to form multinucleated bone-resorbing cells. All aspects of osteoclast formation and functions are regulated by macrophage-colony-stimulating factor (M-CSF) and receptor activator of NF-κB ligand (RANKL), cytokines essential for osteoclast formation and expressed by a variety of cell types, including osteoblast lineage cells. Since the discovery of RANKL in the mid-1990s, mouse genetic and molecular studies have revealed numerous signaling pathways activated by RANKL and M-CSF. More recent studies indicate that osteoclasts and their precursors regulate immune responses and osteoblast formation and functions by means of direct cell-cell contact through ligands and receptors, such as ephrins and Ephs, and semaphorins and plexins, and through expression of clastokines. There is also growing recognition that osteoclasts are immune cells with roles in immune responses beyond mediating the bone destruction that can accompany them. This article reviews recent advances in the understanding of the molecular mechanisms regulating osteoclast formation and functions and their interactions with other cells in normal and pathologic states.
authors.affiliation: University of Rochester Medical Center, 601 Elmwood Avenue, Box 626, Rochester, NY 14642, USA.
authors.forename: B F
authors.initials: BF
authors.lastname: Boyce
mesh_terms: D000818:Animals; D017209:Apoptosis; D016723:Bone Remodeling / Q000502:physiology*; D002450:Cell Communication; D002470:Cell Survival; D016207:Cytokines / Q000502:physiology; D005786:Gene Expression Regulation; D006801:Humans; D016173:Macrophage Colony-Stimulating Factor / Q000502:physiology; D010010:Osteoclasts / Q000166:cytology* / Q000378:metabolism / Q000502:physiology*; D053245:RANK Ligand / Q000502:physiology; D015398:Signal Transduction
chemical_list: D016207:Cytokines; D053245:RANK Ligand; D016173:Macrophage Colony-Stimulating Factor
keywords: apoptosis; bone biology; bone remodeling/regeneration; chemokine(s); cytokine(s); osteoblast(s)
references.citation: J Immunol. 2008 Oct 1;181(7):4742-51
references.pmid: 18802077
references.citation: EMBO J. 2008 Feb 6;27(3):535-45
references.pmid: 18219273
references.citation: Arthritis Res Ther. 2011 Jul 28;13(4):234
references.pmid: 21861861
references.citation: J Clin Invest. 2013 Feb;123(2):666-81
references.pmid: 23321671
references.citation: Nat Med. 2009 Jul;15(7):757-65
references.pmid: 19584867
references.citation: Trends Mol Med. 2006 Jan;12(1):17-25
references.pmid: 16356770
references.citation: Int J Clin Pract. 2012 Dec;66(12):1139-46
references.pmid: 22967310
references.citation: Immunity. 2012 Dec 14;37(6):1024-36
references.pmid: 23200825
references.citation: N Engl J Med. 2002 Jul 18;347(3):175-84
references.pmid: 12124406
references.citation: J Dent Res. 2011 Jul;90(7):841-54
references.pmid: 21248363
references.citation: Semin Cell Dev Biol. 2013 Mar;24(3):163-71
references.pmid: 23022498
references.citation: J Exp Med. 2013 May 6;210(5):969-85
references.pmid: 23569325
references.citation: Genes Dev. 2003 Sep 15;17(18):2205-32
references.pmid: 12975316
references.citation: Nat Rev Endocrinol. 2010 Dec;6(12):698-706
references.pmid: 21045788
references.citation: J Bone Miner Res. 2007 Jul;22(7):992-1001
references.pmid: 17402846
references.citation: J Clin Invest. 2011 Sep;121(9):3505-16
references.pmid: 21841309
references.citation: Dev Cell. 2002 Dec;3(6):889-901
references.pmid: 12479813
references.citation: Nat Med. 2012 Mar 04;18(4):589-94
references.pmid: 22388090
references.citation: Arthritis Res Ther. 2011 May 27;13(3):219
references.pmid: 21635718
references.citation: Nat Med. 2012 Feb 19;18(3):405-12
references.pmid: 22344299
references.citation: Crit Rev Eukaryot Gene Expr. 2009;19(3):171-80
references.pmid: 19883363
references.citation: Cell Metab. 2006 Aug;4(2):111-21
references.pmid: 16890539
references.citation: Ann N Y Acad Sci. 2011 Dec;1240:14-7
references.pmid: 22172034
references.citation: Cancer. 2003 Feb 1;97(3 Suppl):834-9
references.pmid: 12548583
references.citation: J Bone Miner Res. 2012 Feb;27(2):231-9
references.pmid: 22271394
references.citation: Endocr Rev. 2008 Apr;29(2):155-92
references.pmid: 18057140
references.citation: J Bone Miner Res. 2011 Nov;26(11):2665-71
references.pmid: 21735477
references.citation: J Clin Invest. 2009 Oct;119(10):3024-34
references.pmid: 19770515
references.citation: Cell. 2007 Sep 7;130(5):811-23
references.pmid: 17803905
references.citation: J Endocrinol. 2011 Nov;211(2):131-43
references.pmid: 21903860
references.citation: Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7294-9
references.pmid: 23580622
references.citation: Ther Adv Musculoskelet Dis. 2011 Dec;3(6):271-82
references.pmid: 22870485
references.citation: Curr Genomics. 2012 May;13(3):252-63
references.pmid: 23115526
references.citation: J Clin Invest. 2008 Jun;118(6):2088-97
references.pmid: 18464930
references.citation: Bone. 2008 Jan;42(1):19-29
references.pmid: 17936098
references.citation: Bone. 2011 Jul;49(1):34-41
references.pmid: 21111853
references.citation: Rheumatol Int. 2011 Jul;31(7):967-9
references.pmid: 21113810
references.citation: Arthritis Rheum. 2011 Dec;63(12):3908-17
references.pmid: 21898348
references.citation: J Bone Miner Res. 2013 Apr;28(4):711-22
references.pmid: 23436579
references.citation: Nat Med. 2005 Aug;11(8):880-5
references.pmid: 16041384
references.citation: Nat Rev Rheumatol. 2012 Nov;8(11):684-9
references.pmid: 23070645
references.citation: Adv Exp Med Biol. 2010;658:111-6
references.pmid: 19950021
references.citation: Immunol Rev. 2012 Mar;246(1):379-400
references.pmid: 22435567
references.citation: Oral Dis. 2011 Mar;17(2):129-42
references.pmid: 20659257
references.citation: J Bone Miner Res. 2012 Jul;27(7):1439-47
references.pmid: 22706899
references.citation: Immunol Rev. 2005 Dec;208:88-105
references.pmid: 16313343
references.citation: Dev Dyn. 2005 Jan;232(1):1-10
references.pmid: 15580616
references.citation: Clin Investig (Lond). 2011 Dec 1;1(12):1695-1706
references.pmid: 22384312
references.citation: J Bone Miner Res. 2012 Mar;27(3):499-505
references.pmid: 22354849
references.citation: Curr Osteoporos Rep. 2012 Mar;10(1):73-9
references.pmid: 22228398
references.citation: J Exp Med. 2010 Apr 12;207(4):751-62
references.pmid: 20368579
references.citation: Bone. 2007 Feb;40(2):251-64
references.pmid: 17098490
references.citation: Arthritis Res Ther. 2012 Nov 12;14(6):R245
references.pmid: 23146195
references.citation: Bone. 2011 Apr 1;48(4):938-44
references.pmid: 21193069
references.citation: Nat Med. 2004 Jun;10(6):617-24
references.pmid: 15156202
references.citation: J Bone Miner Res. 2013 Apr;28(4):728-35
references.pmid: 22991330
references.citation: Dev Cell. 2005 May;8(5):727-38
references.pmid: 15866163
references.citation: Ann N Y Acad Sci. 2006 Apr;1068:180-6
references.pmid: 16831917
references.citation: Arthritis Rheum. 2011 Apr;63(4):1034-43
references.pmid: 21162099
references.citation: Joint Bone Spine. 2010 Dec;77(6):537-41
references.pmid: 20646949